Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Mar 28, 07:31

Swiss National Bank Boosts Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 24, 06:54

Zacks Research Comments on Novavax FY2027 Earnings

Novavax Inc
Webhose 2025 Mar 19, 18:04

Novavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's Why

Novavax Inc
Webhose 2025 Mar 16, 08:44

Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Brokerages

Novavax Inc
Webhose 2025 Mar 11, 12:35

Novavax announces Young to retire as Chair of the Board, McGlynn to succeed | Markets Insider

Novavax Inc
Webhose 2025 Mar 11, 12:05

Novavax Names Margaret McGlynn Board Chair, Replacing Young

Novavax Inc
Webhose 2025 Mar 11, 08:16

Novavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The Board

Novavax Inc
Webhose 2025 Mar 08, 17:52

Novavax (NASDAQ:NVAX) Stock Price Up 6.7% - Here's Why

Novavax Inc
Webhose 2025 Mar 06, 09:19

SBI Securities Co. Ltd. Buys Shares of 34,485 Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 03, 06:49

What is Zacks Research's Forecast for Novavax Q1 Earnings?

Novavax Inc
Webhose 2025 Mar 02, 09:08

NewEdge Wealth LLC Buys 70,117 Shares of Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 01, 14:03

Zacks Research Has Negative Estimate for Novavax Q4 Earnings

Novavax Inc
Webhose 2025 Mar 01, 12:45

BTIG Research Initiates Coverage on Novavax (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Feb 28, 21:51

Novavax (NASDAQ:NVAX) Issues Quarterly Earnings Results, Beats Expectations By $0.24 EPS

Novavax Inc
Webhose 2025 Feb 28, 19:16

Novavax (NASDAQ:NVAX) Releases Earnings Results, Beats Expectations By $0.24 EPS

Novavax Inc
Webhose 2025 Feb 28, 16:45

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax Inc
Webhose 2025 Feb 28, 16:08

Novavax (NASDAQ:NVAX) Stock Price Up 11.6% After Strong Earnings

Novavax Inc

Latest news

Tommy Yap 2025 Mar 29, 16:00

Week Ahead: U.S. Non-Farm Payrolls Coming Up: What to Expect

Forex Indices
Frances Wang 2025 Mar 27, 16:00

Stock market today: S&P 500, Dow, Nasdaq slip on Trump's tariff escalation

Indices
Frances Wang 2025 Mar 27, 16:00

Forex news today: EUR/USD Struggles to Gain Traction Amid Tariff Threats

Forex
Tommy Yap 2025 Mar 27, 16:00

Morning Note: U.K. Retail Sales, U.S. Core PCE & Canada GDP Outlook

Morning Note Forex
Tommy Yap 2025 Mar 26, 16:00

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Morning Note USD CAD Cryptocurrencies
Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed
Tommy Yap 2025 Mar 25, 16:00

Morning Note: S&P 500 Surges on Tariff Optimism as Tesla Jumps 10%

Morning Note S&P 500 TSLA Oil
Tommy Yap 2025 Mar 25, 16:00

Morning Note: Australia’s Inflation Cools, Japan’s Stays High, UK Awaits Data

Morning Note AUD USD JPY GBP

Info

Spread

0.05

Spread (%)

0.7174 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1125907968

Shares Outstanding

160844000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.23

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot